Patent · US Expired

Pulsed-multiline excitation for color-blind fluorescence detection

US6995841B2 · kind B2 · utility

42Cited by
25References
38Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 28, 2001
Grant dateFeb 7, 2006
Priority date
Expiry dateJun 22, 2022

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2021/6441
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides a technology called Pulse-Multiline Excitation or PME. This technology provides a novel approach to fluorescence detection with application for high-throughput identification of informative SNPs, which could lead to more accurate diagnosis of inherited disease, better prognosis of risk susceptibilities, or identification of sporadic mutations. The PME technology has two main advantages that significantly increase fluorescence sensitivity: (1) optimal excitation of all fluorophores in the genomic assay and (2) “color-blind” detection, which collects considerably more light than standard wavelength resolved detection. Successful implementation of the PME technology will have broad application for routine usage in clinical diagnostics, forensics, and general sequencing methodologies and will have the capability, flexibility, and portability of targeted sequence variation assays for a large majority of the population.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.